Last reviewed · How we verify
NCT07534280
Herbal Tea Extract for Management of Rhinosinusitis
NA trial testing mango leaves extract in Rhino Sinusitis in 30 participants. Completed in 1 March 2026.
10 January 2026
Quick facts
| Lead sponsor | Deraya University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 30 |
| Start date | 20 November 2025 |
| Primary completion | 10 January 2026 |
| Estimated completion | 1 March 2026 |
| Sites | 2 locations across Egypt |
Drugs / interventions tested
- mango leaves extract
- local steroids
- nasal saline — full drug profile →
- amoxicillin clavulanates
Conditions studied
- Rhino Sinusitis — all drugs for Rhino Sinusitis →
Sponsor
Deraya University
Who can join
Adults 18 to 50, any sex, with Rhino Sinusitis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective of this phase I controlled clinical trial is to determine the safety and efficacy of Berry leaves \& Mango leaves mixture in symptomatic treatments on disease-related quality of life in adults with clinically diagnosed acute rhinosinusitis. Ten adult subjects, 18 to 70 years old, who meet the recommended criteria for acute rhinosinusitis, will be enrolled from Minia university ENT outpatient Clinic. Subjects will be advised to add Berry leaves \& Mango leaves herbal tea mixture and followed for one month with their routine therapy (an oral decongestant, a nasal saline spray, and an antitussive agent except analgesic). Subject outcomes will be assessed by telephone interview at 0, 3, 7, 10, and 28 days. The Quality-of-life outcomes are measured on Day 3, 10 and 28 with SNOT-16, a validated evaluative instrument.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07534280
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Deraya University trials
Trials by the same sponsor.
- NCT07528625 — Behavioral Interventions as Primary Prevention for Non-Communicable Diseases Among Young People · NA · not yet recruiting
- NCT07535827 — Insulin Intratympanic Application · EARLY_PHASE1 · enrolling by invitation
- NCT07524686 — Spinal Mobilization With Leg Movement Versus Neurodynamic Mobilization in Lumbar Radiculopathy · NA · completed
- NCT07368517 — Dry Needling for Mechanical Neck Pain · NA · completed
- NCT07523568 — Kinesiotaping Versus Corrective Postural Exercises in Treating Forward Head Posture · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07534280 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Deraya University
- Last refreshed: 16 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07534280.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing